Regencell Shares Edge Down After New Lawsuit Notice
Regencell Bioscience Holdings Ltd shares dropped during Tuesday morning, as a new investor alert focused attention on a securities class action deadline set for later this month. The company, listed on Nasdaq, has seen volatile trading in its shares. The Hong Kong-listed bioscience name saw its shares last change hands at $23.51, off 66 cents, or 2.7%. RGC kicked off the day at $24.10 and moved between $23.50 and $24.38. Volume was about 33,600 shares, according to the most recent data.